{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:20:58Z","timestamp":1790364058372,"version":"4.1.0"},"reference-count":51,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>A systematic review from 1 January to 30 June 2020 revealed 42 patients with Guillain-Barr\u00e9 syndrome (GBS) associated with SARS-CoV-2 infection. Single cases and small series were reported from 13 countries, the majority from Europe (79.4%) and especially from Italy (30.9%). SARS-CoV-2 infection was demonstrated by nasopharyngeal swab (85.7%) and serology (14.3%). Median time between COVID-19 and GBS onset in 36 patients was 11.5 days (IQR: 7.7\u201316). The most common clinical features were: limb weakness (76.2%), hypoareflexia (80.9 %), sensory disturbances (66.7 %) and facial palsy (38.1%). Dysautonomia occurred in 19%, respiratory failure in 33.3% and 40.5% of patients were admitted in intensive care unit. Most patients (71.4%) had the classical clinical presentation but virtually all GBS variants and subtypes were reported. Cerebrospinal fluid (CSF) albumin-cytological dissociation was found in 28\/36 (77.8%) and PCR for SARS-CoV-2 was negative in 25\/25 patients. Electrodiagnosis was demyelinating in 80.5% and levels 1 and 2 of Brighton criteria of diagnostic certainty, when applicable, were fulfilled in 94.5% patients. Antiganglioside antibodies were positive in only 1\/22 patients. Treatments were intravenous immunoglobulin and\/or plasma exchange (92.8%) with, at short-time follow-up, definite improvement or recovery in 62.1% of patients. One patient died. In conclusion, the most frequent phenotype of GBS in SARS-CoV-2 infection is the classical sensorimotor demyelinating GBS responding to the usual treatments. The time interval between infectious and neuropathic symptoms, absence of CSF pleocytosis and negative PCR support a postinfectious mechanism. The abundance of reports suggests a pathogenic link between SARS-CoV-2 infection and GBS but a case-control study is greatly needed.<\/jats:p>","DOI":"10.1136\/jnnp-2020-324491","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:18:42Z","timestamp":1598570322000},"page":"1105-1110","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic"],"prefix":"10.1136","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-8912","authenticated-orcid":false,"given":"Antonino","family":"Uncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"2024111108050902000_91.10.1105.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024111108050902000_91.10.1105.2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir074"},{"key":"2024111108050902000_91.10.1105.3","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.811119"},{"key":"2024111108050902000_91.10.1105.4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"The Lancet"},{"key":"2024111108050902000_91.10.1105.5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13552"},{"key":"2024111108050902000_91.10.1105.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003"},{"key":"2024111108050902000_91.10.1105.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.138"},{"key":"2024111108050902000_91.10.1105.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2024111108050902000_91.10.1105.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2024111108050902000_91.10.1105.10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.neurol.2020.04.003","article-title":"COVID-19 may induce Guillain-Barr\u00e9 syndrome","volume":"176","author":"Camdessanche","year":"2020","journal-title":"Rev Neurol"},{"key":"2024111108050902000_91.10.1105.11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2024111108050902000_91.10.1105.12","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"2024111108050902000_91.10.1105.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619"},{"key":"2024111108050902000_91.10.1105.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e00771","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"20","author":"Virani","year":"2020","journal-title":"IDCases"},{"key":"2024111108050902000_91.10.1105.15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nrl.2020.04.007","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"35","author":"Velayos Gal\u00e1n","year":"2020","journal-title":"Neurologia"},{"key":"2024111108050902000_91.10.1105.16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","article-title":"Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence!","volume":"176","author":"El Otmani","year":"2020","journal-title":"Rev Neurol"},{"key":"2024111108050902000_91.10.1105.17","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: new infection, old complication?","volume":"267","author":"Padroni","year":"2020","journal-title":"J Neurol"},{"key":"2024111108050902000_91.10.1105.18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2020.04.074","article-title":"Guillain-Barr\u00e9 syndrome as a complication of SARS-CoV-2 infection","volume":"87","author":"Coen","year":"2020","journal-title":"Brain Behav Immun"},{"key":"2024111108050902000_91.10.1105.19","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000741"},{"key":"2024111108050902000_91.10.1105.20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.clinph.2020.05.003","article-title":"Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome","volume":"131","author":"Arnaud","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"2024111108050902000_91.10.1105.21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10072-020-04449-8","article-title":"Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital","volume":"41","author":"Ottaviani","year":"2020","journal-title":"Neurol Sci"},{"key":"2024111108050902000_91.10.1105.22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jocn.2020.05.016","article-title":"Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 syndrome as a rare neurological complication of SARS-CoV-2","volume":"77","author":"Juliao Caama\u00f1o","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2024111108050902000_91.10.1105.23","doi-asserted-by":"crossref","unstructured":"Gigli GL , Bax F , Marini A , et al . Guillain-Barr\u00e9 syndrome in the COVID-19 era: just an occasional cluster? J Neurol 2020:1\u20133.","DOI":"10.1007\/s00415-020-09911-3"},{"key":"2024111108050902000_91.10.1105.24","doi-asserted-by":"crossref","unstructured":"Riva N , Russo T , Falzone YM , et al . Post-Infectious Guillain-Barr\u00e9 syndrome related to SARS-CoV-2 infection: a case report. J Neurol 2020. [Epub ahead of print: 26 May 2020].","DOI":"10.1007\/s00415-020-09907-z"},{"key":"2024111108050902000_91.10.1105.25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jns.12382","article-title":"Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature","volume":"25","author":"Scheidl","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"2024111108050902000_91.10.1105.26","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Dom\u00ednguez J , Ameijide-Sanluis E , Garc\u00eda-Cabo C , et al . Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol 2020:1\u20132.","DOI":"10.1007\/s00415-020-09912-2"},{"key":"2024111108050902000_91.10.1105.27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000785"},{"key":"2024111108050902000_91.10.1105.28","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","article-title":"New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","volume":"41","author":"Assini","year":"2020","journal-title":"Neurol Sci"},{"key":"2024111108050902000_91.10.1105.29","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6609"},{"key":"2024111108050902000_91.10.1105.30","doi-asserted-by":"crossref","unstructured":"Chan JL , Ebadi H , Sarna JR . Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci 2020:1\u20133.","DOI":"10.1017\/cjn.2020.106"},{"key":"2024111108050902000_91.10.1105.31","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14368","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with favorable outcome","author":"Lascano","year":"2020","journal-title":"Eur J Neurol"},{"key":"2024111108050902000_91.10.1105.32","doi-asserted-by":"crossref","unstructured":"Oguz-Akarsu E , Ozpar R , Mirzayev H , et al . Guillain-Barr\u00e9 syndrome in a patient with minimal symptoms of COVID-19 infection. Muscle Nerve 2020. [Epub ahead of print: 4 Jun 2020].","DOI":"10.1002\/mus.26992"},{"key":"2024111108050902000_91.10.1105.33","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0213"},{"key":"2024111108050902000_91.10.1105.34","doi-asserted-by":"crossref","unstructured":"Manganotti P , Pesavento V , Buoite Stella A , et al . Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol 2020:1\u20132.","DOI":"10.1007\/s13365-020-00858-9"},{"key":"2024111108050902000_91.10.1105.35","doi-asserted-by":"crossref","unstructured":"Helbok R , Beer R , Loscher W , et al . Guillain-Barr\u00e9 syndrome in a patient with antibodies against SARS-CoV-2. Eur J Neurol 2020.","DOI":"10.1111\/ene.14388"},{"key":"2024111108050902000_91.10.1105.36","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14398","article-title":"Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection","author":"Kilinc","year":"2020","journal-title":"Eur J Neurol"},{"key":"2024111108050902000_91.10.1105.37","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236182","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication","volume":"13","author":"Webb","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2024111108050902000_91.10.1105.38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CND.0000000000000309","article-title":"Novel Coronavirus (COVID-19)-Associated Guillain-Barr\u00e9 Syndrome: Case Report","volume":"21","author":"Rana","year":"2020","journal-title":"J Clin Neuromuscul Dis"},{"key":"2024111108050902000_91.10.1105.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577294","article-title":"Guillain-Barr\u00e9 syndrome in a patient infected with SARS-CoV-2, a case report","volume":"346","author":"Farzi","year":"2020","journal-title":"J Neuroimmunol"},{"key":"2024111108050902000_91.10.1105.40","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14383","article-title":"Miller-Fisher syndrome after SARS-CoV-2 infection","author":"Reyes-Bueno","year":"2020","journal-title":"Eur J Neurol"},{"key":"2024111108050902000_91.10.1105.41","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A6654","article-title":"Covid-19-associated bifacial weakness with paresthesia subtype of Guillain-Barr\u00e9 syndrome","author":"Hutchins","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"2024111108050902000_91.10.1105.42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"2024111108050902000_91.10.1105.43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024111108050902000_91.10.1105.44","doi-asserted-by":"publisher","DOI":"10.3390\/v12010014"},{"key":"2024111108050902000_91.10.1105.45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2024111108050902000_91.10.1105.46","doi-asserted-by":"publisher","DOI":"10.1177\/1941874414535215"},{"key":"2024111108050902000_91.10.1105.47","article-title":"Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study","author":"Qin","year":"2020","journal-title":"medRxiv"},{"key":"2024111108050902000_91.10.1105.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.012"},{"key":"2024111108050902000_91.10.1105.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008264","article-title":"Guillain-Barr\u00e9 syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype","volume":"14","author":"Leonhard","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2024111108050902000_91.10.1105.50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.51.4.1226","article-title":"Chloroquine myopathy and neuropathy with elevated CSF protein","volume":"51","author":"Wasay","year":"1998","journal-title":"Neurology"},{"key":"2024111108050902000_91.10.1105.51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21484"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-324491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T16:06:35Z","timestamp":1731341195000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-324491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,15]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/jnnp-2020-324491"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-324491","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}